The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Molecular Pharming Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Molecular Pharming Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1754309

No of Pages : 111

Synopsis
The global Molecular Pharming market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
This report is a detailed and comprehensive analysis for global Molecular Pharming market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Molecular Pharming market size and forecasts, in consumption value ($ Million), 2018-2029
Global Molecular Pharming market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Molecular Pharming market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Molecular Pharming market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Pharming
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Pharming market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited and mozza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Molecular Pharming market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gene Gun
Agroinfiltration
Electroporation
Agrobacterium-Mediated Gene Transfer
Market segment by Application
Recombinant Antibodies
Hormones, Vaccines
Industrial Enzymes
Proteins & Protein-Based Materials
Technical Reagents
Nutritional Products
Market segment by players, this report covers
Medicago Inc
Meristem Therapeutics S.A. (Ventria Bioscience)
Miruku
Moolec Science Limited
mozza
Nobell Foods
Agrenvec S.L
Bright Biotech
Core Biogenesis
Diamante SRL
Leaf Systems International Limited
ORF Genetics
Pfizer, Inc.
ProdiGene Inc
Protalix Biotherapeutics, Inc
Tiamat Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Pharming product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Pharming, with revenue, gross margin and global market share of Molecular Pharming from 2018 to 2023.
Chapter 3, the Molecular Pharming competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Molecular Pharming market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Pharming.
Chapter 13, to describe Molecular Pharming research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of Molecular Pharming
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Molecular Pharming by Type
1.3.1 Overview: Global Molecular Pharming Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Molecular Pharming Consumption Value Market Share by Type in 2022
1.3.3 Gene Gun
1.3.4 Agroinfiltration
1.3.5 Electroporation
1.3.6 Agrobacterium-Mediated Gene Transfer
1.4 Global Molecular Pharming Market by Application
1.4.1 Overview: Global Molecular Pharming Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Recombinant Antibodies
1.4.3 Hormones, Vaccines
1.4.4 Industrial Enzymes
1.4.5 Proteins & Protein-Based Materials
1.4.6 Technical Reagents
1.4.7 Nutritional Products
1.5 Global Molecular Pharming Market Size & Forecast
1.6 Global Molecular Pharming Market Size and Forecast by Region
1.6.1 Global Molecular Pharming Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Molecular Pharming Market Size by Region, (2018-2029)
1.6.3 North America Molecular Pharming Market Size and Prospect (2018-2029)
1.6.4 Europe Molecular Pharming Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Molecular Pharming Market Size and Prospect (2018-2029)
1.6.6 South America Molecular Pharming Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Molecular Pharming Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Medicago Inc
2.1.1 Medicago Inc Details
2.1.2 Medicago Inc Major Business
2.1.3 Medicago Inc Molecular Pharming Product and Solutions
2.1.4 Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medicago Inc Recent Developments and Future Plans
2.2 Meristem Therapeutics S.A. (Ventria Bioscience)
2.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Details
2.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Major Business
2.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product and Solutions
2.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Developments and Future Plans
2.3 Miruku
2.3.1 Miruku Details
2.3.2 Miruku Major Business
2.3.3 Miruku Molecular Pharming Product and Solutions
2.3.4 Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Miruku Recent Developments and Future Plans
2.4 Moolec Science Limited
2.4.1 Moolec Science Limited Details
2.4.2 Moolec Science Limited Major Business
2.4.3 Moolec Science Limited Molecular Pharming Product and Solutions
2.4.4 Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moolec Science Limited Recent Developments and Future Plans
2.5 mozza
2.5.1 mozza Details
2.5.2 mozza Major Business
2.5.3 mozza Molecular Pharming Product and Solutions
2.5.4 mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 mozza Recent Developments and Future Plans
2.6 Nobell Foods
2.6.1 Nobell Foods Details
2.6.2 Nobell Foods Major Business
2.6.3 Nobell Foods Molecular Pharming Product and Solutions
2.6.4 Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nobell Foods Recent Developments and Future Plans
2.7 Agrenvec S.L
2.7.1 Agrenvec S.L Details
2.7.2 Agrenvec S.L Major Business
2.7.3 Agrenvec S.L Molecular Pharming Product and Solutions
2.7.4 Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Agrenvec S.L Recent Developments and Future Plans
2.8 Bright Biotech
2.8.1 Bright Biotech Details
2.8.2 Bright Biotech Major Business
2.8.3 Bright Biotech Molecular Pharming Product and Solutions
2.8.4 Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bright Biotech Recent Developments and Future Plans
2.9 Core Biogenesis
2.9.1 Core Biogenesis Details
2.9.2 Core Biogenesis Major Business
2.9.3 Core Biogenesis Molecular Pharming Product and Solutions
2.9.4 Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Core Biogenesis Recent Developments and Future Plans
2.10 Diamante SRL
2.10.1 Diamante SRL Details
2.10.2 Diamante SRL Major Business
2.10.3 Diamante SRL Molecular Pharming Product and Solutions
2.10.4 Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Diamante SRL Recent Developments and Future Plans
2.11 Leaf Systems International Limited
2.11.1 Leaf Systems International Limited Details
2.11.2 Leaf Systems International Limited Major Business
2.11.3 Leaf Systems International Limited Molecular Pharming Product and Solutions
2.11.4 Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Leaf Systems International Limited Recent Developments and Future Plans
2.12 ORF Genetics
2.12.1 ORF Genetics Details
2.12.2 ORF Genetics Major Business
2.12.3 ORF Genetics Molecular Pharming Product and Solutions
2.12.4 ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 ORF Genetics Recent Developments and Future Plans
2.13 Pfizer, Inc.
2.13.1 Pfizer, Inc. Details
2.13.2 Pfizer, Inc. Major Business
2.13.3 Pfizer, Inc. Molecular Pharming Product and Solutions
2.13.4 Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer, Inc. Recent Developments and Future Plans
2.14 ProdiGene Inc
2.14.1 ProdiGene Inc Details
2.14.2 ProdiGene Inc Major Business
2.14.3 ProdiGene Inc Molecular Pharming Product and Solutions
2.14.4 ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ProdiGene Inc Recent Developments and Future Plans
2.15 Protalix Biotherapeutics, Inc
2.15.1 Protalix Biotherapeutics, Inc Details
2.15.2 Protalix Biotherapeutics, Inc Major Business
2.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Product and Solutions
2.15.4 Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Protalix Biotherapeutics, Inc Recent Developments and Future Plans
2.16 Tiamat Sciences
2.16.1 Tiamat Sciences Details
2.16.2 Tiamat Sciences Major Business
2.16.3 Tiamat Sciences Molecular Pharming Product and Solutions
2.16.4 Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Tiamat Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Molecular Pharming Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Molecular Pharming by Company Revenue
3.2.2 Top 3 Molecular Pharming Players Market Share in 2022
3.2.3 Top 6 Molecular Pharming Players Market Share in 2022
3.3 Molecular Pharming Market: Overall Company Footprint Analysis
3.3.1 Molecular Pharming Market: Region Footprint
3.3.2 Molecular Pharming Market: Company Product Type Footprint
3.3.3 Molecular Pharming Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Molecular Pharming Consumption Value and Market Share by Type (2018-2023)
4.2 Global Molecular Pharming Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Molecular Pharming Consumption Value Market Share by Application (2018-2023)
5.2 Global Molecular Pharming Market Forecast by Application (2024-2029)
6 North America
6.1 North America Molecular Pharming Consumption Value by Type (2018-2029)
6.2 North America Molecular Pharming Consumption Value by Application (2018-2029)
6.3 North America Molecular Pharming Market Size by Country
6.3.1 North America Molecular Pharming Consumption Value by Country (2018-2029)
6.3.2 United States Molecular Pharming Market Size and Forecast (2018-2029)
6.3.3 Canada Molecular Pharming Market Size and Forecast (2018-2029)
6.3.4 Mexico Molecular Pharming Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Molecular Pharming Consumption Value by Type (2018-2029)
7.2 Europe Molecular Pharming Consumption Value by Application (2018-2029)
7.3 Europe Molecular Pharming Market Size by Country
7.3.1 Europe Molecular Pharming Consumption Value by Country (2018-2029)
7.3.2 Germany Molecular Pharming Market Size and Forecast (2018-2029)
7.3.3 France Molecular Pharming Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Molecular Pharming Market Size and Forecast (2018-2029)
7.3.5 Russia Molecular Pharming Market Size and Forecast (2018-2029)
7.3.6 Italy Molecular Pharming Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Molecular Pharming Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Molecular Pharming Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Molecular Pharming Market Size by Region
8.3.1 Asia-Pacific Molecular Pharming Consumption Value by Region (2018-2029)
8.3.2 China Molecular Pharming Market Size and Forecast (2018-2029)
8.3.3 Japan Molecular Pharming Market Size and Forecast (2018-2029)
8.3.4 South Korea Molecular Pharming Market Size and Forecast (2018-2029)
8.3.5 India Molecular Pharming Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Molecular Pharming Market Size and Forecast (2018-2029)
8.3.7 Australia Molecular Pharming Market Size and Forecast (2018-2029)
9 South America
9.1 South America Molecular Pharming Consumption Value by Type (2018-2029)
9.2 South America Molecular Pharming Consumption Value by Application (2018-2029)
9.3 South America Molecular Pharming Market Size by Country
9.3.1 South America Molecular Pharming Consumption Value by Country (2018-2029)
9.3.2 Brazil Molecular Pharming Market Size and Forecast (2018-2029)
9.3.3 Argentina Molecular Pharming Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Molecular Pharming Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Molecular Pharming Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Molecular Pharming Market Size by Country
10.3.1 Middle East & Africa Molecular Pharming Consumption Value by Country (2018-2029)
10.3.2 Turkey Molecular Pharming Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Molecular Pharming Market Size and Forecast (2018-2029)
10.3.4 UAE Molecular Pharming Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Molecular Pharming Market Drivers
11.2 Molecular Pharming Market Restraints
11.3 Molecular Pharming Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Molecular Pharming Industry Chain
12.2 Molecular Pharming Upstream Analysis
12.3 Molecular Pharming Midstream Analysis
12.4 Molecular Pharming Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’